Meeting News CoverageVideo

VIDEO: Wigley discusses treatment advances for scleroderma

DESTIN, Fla. — At the Congress of Clinical Rheumatology Annual Meeting, Fredrick M. Wigley, MD, spoke about treatment advances for patients with scleroderma. He said the disease expression is heterogeneous and it is important rheumatologists clearly define the clinical phenotype.

DESTIN, Fla. — At the Congress of Clinical Rheumatology Annual Meeting, Fredrick M. Wigley, MD, spoke about treatment advances for patients with scleroderma. He said the disease expression is heterogeneous and it is important rheumatologists clearly define the clinical phenotype.

    See more from Congress of Clinical Rheumatology Annual Meeting